Nmblr Convince - Craft a Compelling Value Story

1. What a value proposition is

A value proposition is a clear statement that explains how your product solves an important problem, the specific benefits it delivers, and why stakeholders should choose it over alternatives.

In biopharma, that promise has four connected parts:

• Disease burden & unmet need – the clinical, human/institutional and system cost of the current situation.
• Clinical value – how your product changes outcomes and risk.
• Humanistic / institutional value – how it improves experience, workflow, safety, reputation or equity.
• Economic value – how it translates those improvements into resource, budget and productivity impact.

Nmblr Convince structures this into core statements plus supporting messages for each dimension, all anchored in the same disease burden story.

2. Why it matters

A strong value proposition:

• Answers the real question: “Why should I choose this option?” for payers, HCPs and institutions.
• Differentiates your brand, not just on features, but on outcomes and impact that matter to stakeholders.
• Aligns strategy and execution – evidence plans, access strategy, brand positioning and messaging and customer engagement all pull in the same direction.
• Improves pull-through and adoption by giving field teams a coherent, evidence-backed narrative at every stage of the buying and access process.

Without it, you get scattered claims, inconsistent stories across markets, and value that feels “nice to have” rather than essential.

3. The problems solved by this move

Nmblr Convince is designed to fix some familiar pain points in value story work:

1. Unstructured value discussions
   • Teams jump between unmet need, data points and economics without a clear backbone.
   • Convince provides a framework – disease burden → clinical → humanistic / institutional → economic – so everyone builds on the same foundation.
2. Clinical-heavy, value-light stories
   • Decks are rich in endpoints but thin on what they mean for people, institutions and budgets.
   • Convince makes each team explicitly translate clinical effects into humanistic and economic consequences.
3. Disconnected messages by function or market
   • Access, medical, marketing and affiliates each create their own flavour of value story.
   • Convince brings them into one collaborative space, encouraging diverse perspectives but forcing a single, aligned narrative.
4. Claims without ladders of proof
   • Big headline statements are made with weak or scattered evidence.
   • Convince requires supporting messages and data to back every supporting statement, so the story is both compelling and defensible.
5. Generic propositions that ignore strategic choices
   • Value stories that could belong to any brand in the class.
   • Convince ties value creation back to your specific target patient population, the leverage points and positioning, so the proposition feels uniquely yours.

4. Linking Convince to the “Winning Focus” and Positioning

Think of Nmblr as a flow:

• Pathfinder / “Winning Focus” – where and how you intend to win.
• Nmblr Edge (Positioning) – the distinct space you want to own in customers’ minds.
• Nmblr Convince – the detailed value story that aligns to the promise.

For Convince to work:

• Every value idea must serve the Winning Focus.
  • If your focus is, say, improving early appropriate initiation in a specific segment, disease burden, clinical, humanistic and economic claims should all reinforce why that change matters most.
• The value story must express – not fight – the Positioning.
  • If your positioning is about “confident, earlier intervention,” messages that suggest “last resort rescue” will dilute it.
  • The proposition should make your chosen position feel inevitable and rational.
• All four dimensions should line up like a spine:
  • Disease burden & unmet need → explains the stakes in your chosen focus area.
  • Clinical value → shows how you change that burden.
  • Humanistic / institutional value → shows what this means for people and systems.
  • Economic value → shows why investing in that change is sound.

If an idea doesn’t advance that spine, Convince helps you capture it, park it, or reshape it so it supports the Winning Focus and positioning rather than distracting from them.

5. When to revisit the value proposition

Your value proposition is not a one-off paragraph in the core deck; it should evolve as your evidence and environment change.

Good moments to re-open Convince include:

• Major data or label events
  • Pivotal readouts, new indications, line extensions, important safety or RWE findings.
• Access and policy milestones
  • HTA decisions, new contracts, guideline changes, formulary wins or losses.
• Shifts in competition or standard of care
  • New entrants, new MoAs, new generics or biosimilars that change the economics.
• Lifecycle and strategic shifts
  • Moving from launch to growth, defending against erosion, repositioning in a new segment, or updating your Winning Focus.
• Signals from the field
  • Feedback that certain claims do not resonate, or that different aspects of value are driving decisions than originally assumed.

Each revisit is about refining and re-weighting the story, not ripping it up: tightening statements, updating evidence, and adjusting the balance across clinical, humanistic and economic value.

6. Critical success factors

To get full value from Nmblr Convince, a few conditions really matter:

1. Single, sharp disease burden & unmet need story
   • One agreed “problem statement” that sets the context for all value statements.
   • Everyone can explain, in simple language, what is at stake if nothing changes.
2. Integrated value, not silos
   • Clinical, humanistic / institutional and economic value are developed in relation to each other, not in separate workstreams.
   • Humanistic and institutional value reinforces clinical impact; economics translates both into resource and budget terms.
3. Evidence-backed ladders
   • Every headline statement has supporting messages under it, and every supporting message has identified data behind it (or a plan to generate it).
   • Assumptions and gaps are visible so evidence planning can target them.
4. Cross-functional, cross-market collaboration
   • Medical, HEOR, access, marketing, patient engagement and key markets contribute.
   • Convince is used as a shared space to shape, debate and refine the value story together.
5. Tight connection to Winning Focus and Positioning
   • Each value statement is explicitly checked against your chosen focus areas and brand positioning.
   • If it doesn’t reinforce them, it’s reworked or removed.
6. Clarity for specific audiences and decisions
   • You know which parts of the story matter most to payers, HCPs, institutions and patients, and how they show up at key decision points.
7. Commitment to test and refine
   • The team actively tests the story (research, advisory boards, field feedback) and uses the insights to sharpen statements and proof.

Used this way, Nmblr Convince doesn’t just “fill in” a value prop template – it becomes the move that links your strategy to a persuasive, evidence-led narrative that payers, HCPs and institutions can genuinely believe in.

A powerful Core Value Story starts with the problem (burden & unmet need) and proves—with restraint and rigor—how your asset creates clinical, humanistic/institutional, and economic value.

The problems solved by this move

• Alignment and Clarity: A structured value story eliminates internal silos and redundancies, ensuring all teams (medical, clinical, HEOR, market access) are aligned and communicate a consistent value message, both internally and externally.
• Stakeholder Relevance: It helps distill complex evidence into messages tailored for HCPs, payors, and patients, articulating how the brand solves real-world burdens and unmet needs instead of solely pushing product attributes.
• Strategic Differentiation: Engaging, evidence-driven stories differentiate the asset in a crowded marketplace, supporting crucial milestones such as reimbursement, adoption, and market access.

Why having a ‘Core Value Story’ matters

• Stakeholder Engagement: A compelling value story is more persuasive than standalone data or statistics. By first connecting emotionally and then substantiating claims with robust evidence, it fosters engagement, trust, and advocacy among key stakeholders.
• Global Consistency: It provides a unified narrative that can be adapted for local markets, supporting brand launches and payer negotiations with clarity and cohesion.
• Decision Impact: Stakeholders—including payors and HCPs—require clear articulation of how the product improves clinical outcomes, patient quality of life, and healthcare spending

How Nmblr Convince helps teams build, stress-test and operationalize the Core Value Story

• End-to-End Integration: Nmblr Convince enables cross-functional co-creation of the value strategy, weaving together scientific, health economic, and stakeholder insights into a single, coherent value narrative.
• Evidence Repository: It acts as a central hub (Value & Evidence Platform) for collecting, organizing, and pressure-testing key messages, supporting evidence, and future research needs.
• Stakeholder Testing: It makes it easy for Value stories to be iteratively tested and refined with internal stakeholders and external experts (e.g., payors, KOLs) to ensure clarity, credibility, and relevance.

When to revisit your core value story and supporting evidence

Revisit the story at these trigger points (and update the linked evidence):

• New data: topline, subgroup, safety update, real-world evidence, meta-analysis.
• Milestones: end of Phase II; Phase III readout; label negotiations; launch; post-launch QBRs.
• External changes: guideline updates, competitor entry, new HTA decisions, supply constraints, pricing/contracting shifts.
• Performance signals: loss in a formulary decision, access hurdles, unexpected objections, adherence/persistence gaps.
• Planning cycles: annual brand planning, budget impact refresh, AMCP/Formulary dossier updates.

Critical success factors

• Factor 1: Cross-Functional Collaboration: Effective value stories are created by integrated teams—clinical, HEOR, medical, commercial—working in harmony and aligned on evidence and key messages.
• Factor 2: Patient-Centric Framing: Start by making the disease burden and unmet need tangible. Use real patient journeys and emotional triggers to set up the clinical, humanistic, and economic rationale for the asset.
• Factor 3: Evidence-Based Support: All messages must be backed by credible clinical, real-world, humanistic, and economic evidence, organized and referenced in a way that’s easily accessible for various stakeholders.
• Factor 4: Continuous Refinement: Engage stakeholders early and often, test the story internally and externally, and refine based on data and feedback.